Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer

about

Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer

Item

http://www.wikidata.org/entity/Q58706995

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 21 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@en

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@nl

type

Item

label

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@en

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@nl

prefLabel

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@en

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@nl

P1476

Worth a local treatment? - Ana ...... ligometastatic prostate cancer

@en

P2093

A Baehr

http://www.w3.org/2001/XMLSchema#string

H-T Eich

http://www.w3.org/2001/XMLSchema#string

K Kroeger

http://www.w3.org/2001/XMLSchema#string

L Stegger

http://www.w3.org/2001/XMLSchema#string

M Schäfers

http://www.w3.org/2001/XMLSchema#string

S Scobioala

http://www.w3.org/2001/XMLSchema#string

U Haverkamp

http://www.w3.org/2001/XMLSchema#string

P2860

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer

The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer.

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer.

State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83).

Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients.

Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.

P2888

s13014-018-1118-7

P304

185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-018-1118-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Oertel

P577

2018-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107123549

http://www.w3.org/2001/XMLSchema#string

P698

30241556

http://www.w3.org/2001/XMLSchema#string

P932

6150968

http://www.w3.org/2001/XMLSchema#string